Related Experiment Video
Updated: Jul 24, 2026
13:07
Simultaneous Intracellular Recording of a Lumbar Motoneuron and the Force Produced by its Motor Unit in the Adult Mouse In vivo
Published on: December 5, 2012
Prolonged mivacurium-induced neuromuscular block. Case report
R Arcioni1, M Sanfilippo, R Romano
1Anesthesia and Intensive Care Medicine Institute, University of Rome, La Sapienza.
Minerva Anestesiologica
|December 22, 1999
Summary
This study observed prolonged neuromuscular blockade recovery after mivacurium administration during general anesthesia for elective surgery. Patients experienced delayed recovery, necessitating extended monitoring and ventilation post-procedure.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- General anesthesia involves balancing patient safety and surgical needs.
- Neuromuscular blocking agents are crucial for intubation and surgical relaxation.
- Mivacurium, a short-acting neuromuscular blocker, is commonly used in anesthesia.
Observation:
- A patient undergoing elective surgery experienced an unusually long recovery from neuromuscular blockade.
- Neuromuscular monitoring revealed delayed recovery signs after mivacurium administration.
- Tracheal extubation was performed when neuromuscular function (T1) reached 80% and 98% of control values.
Findings:
- Recovery from neuromuscular block after mivacurium was significantly delayed, with initial signs appearing after 255 minutes.
- Full neuromuscular recovery (T1 at 98%) was achieved 417 minutes after mivacurium administration.
- This contrasts with a previous uneventful anesthetic experience using vecuronium bromide.
Implications:
- Prolonged neuromuscular blockade can increase the risk of postoperative respiratory complications.
- Careful patient selection and monitoring are essential when using mivacurium.
- Further research is needed to understand the causes of prolonged mivacurium-induced neuromuscular blockade.
Related Concept Videos
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...